Home > Financial Ratios > SEQUENT SCIENTIFIC

SEQUENT SCIENTIFIC
Core EBITDA Growth

    Back to All Ratios
SEQUENT SCIENTIFIC is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SEQUENT SCIENTIFIC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 143.86294.50-84.74-45.4522.18

What is the latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC ?

The latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC is 143.86 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025143.86
Mar2024294.50
Mar2023-84.74
Mar2022-45.45
Mar202122.18

How is Core EBITDA Growth of SEQUENT SCIENTIFIC Trending?

Years Core EBITDA Growth % Change
Mar2025 143.86
-51.15
Mar2024 294.5
Positive
Mar2023 -84.74
Negative
Mar2022 -45.45
Negative
Mar2021 22.18 -

Other Financial Ratios of SEQUENT SCIENTIFIC


Compare Core EBITDA Growth ratio of peers of SEQUENT SCIENTIFIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC ₹9,179.3 Cr 1.6% 7.6% 62.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,083.0 Cr -1% -7% -1% Stock Analytics
DIVIS LABORATORIES ₹163,971.0 Cr 5% -2.7% 15.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,660.0 Cr 3.2% -6.2% 29.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,686.0 Cr 2.3% -8.1% 13.5% Stock Analytics
CIPLA ₹99,086.7 Cr 0.9% -7.8% -12.5% Stock Analytics


SEQUENT SCIENTIFIC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC

1.6%

7.6%

62.7%

SENSEX

4.7%

-0.1%

3.6%


You may also like the below Video Courses